Kroencke Sylvia, Schulz Karl-Heinz, Nashan Björn, Koch Martina
Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
University Transplant Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Clin Transplant. 2015 Nov;29(11):1029-38. doi: 10.1111/ctr.12625. Epub 2015 Oct 5.
A fundamental goal in living kidney donation (LKD) is to maximize donor safety while minimizing post-operative impairments. We evaluated clinical outcome and health-related quality of life (QOL) comparing anterior vertical mini-incision donor nephrectomy (MIDN) and retroperitoneoscopic donor nephrectomy (RPDN).
Thirty-eight MIDN and 45 RPDN donors were analyzed. In a subsample (n = 18 MIDN; n = 32 RPDN), QOL was prospectively assessed with the WHOQOL-Bref questionnaire before and three months after LKD.
Skin-to-skin time (169 vs. 116 min, p < 0.001) and hospital stay (6.6 vs. 4.9 d, p < 0.001) were significantly shorter in RPDN. In total, 26% of MIDN patients and 13% of RPDN patients developed post-operative complications (p = 0.14). While in MIDN the QOL domains physical health (p = 0.03) and psychological (p = 0.03) and the overall QOL facet (p = 0.003) were significantly lower three months post-LKD compared to baseline, there were no significant QOL decreases in RPDN. However, no significant post-operative QOL differences were found between groups. RPDN donors retrospectively reported significantly less post-operative pain (p = 0.007) and physical strain (p = 0.05) caused by LKD than MIDN donors.
It may be possible to further reduce the surgical burden of LKD by introducing RPDN. Post-operative QOL was not significantly different between groups, but the QOL decrease appeared to be less pronounced in RPDN.
活体肾移植(LKD)的一个基本目标是在将术后损伤降至最低的同时,最大限度地提高供体安全性。我们比较了前正中垂直小切口供肾切除术(MIDN)和后腹腔镜供肾切除术(RPDN)的临床结局及健康相关生活质量(QOL)。
分析了38例接受MIDN的供体和45例接受RPDN的供体。在一个亚样本中(18例MIDN;32例RPDN),在活体肾移植术前和术后3个月,采用世界卫生组织生活质量简表(WHOQOL-Bref)对生活质量进行前瞻性评估。
RPDN的皮肤对皮肤时间(169分钟对116分钟,p<0.001)和住院时间(6.6天对4.9天,p<0.001)显著更短。总体而言,26%的MIDN患者和13%的RPDN患者发生术后并发症(p=0.14)。虽然在MIDN中,与基线相比,活体肾移植术后3个月的生活质量领域身体健康(p=0.03)、心理(p=0.03)和总体生活质量方面(p=0.003)显著降低,但RPDN中生活质量没有显著下降。然而,两组之间术后生活质量没有显著差异。与MIDN供体相比,RPDN供体回顾性报告活体肾移植引起的术后疼痛(p=0.007)和身体劳损(p=0.05)明显更少。
引入RPDN可能进一步减轻活体肾移植的手术负担。两组之间术后生活质量没有显著差异,但RPDN中生活质量的下降似乎不太明显。